Erkan et al. developed a pathologic scoring system called the activated stroma index (ASI), which is defined as the ratio of αSMA-stained area to collagen-stained area in the tumor bed (Erkan et al., 2008). The gene discussed is ACTA1; the disease is neoplasm.